Li Xiaojing, Wang Xinmu, Miao Yuwen, Yang Guoli, Gao Bo, Dong Yan
Department of Prosthodontics, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China.
Email:
Zhonghua Kou Qiang Yi Xue Za Zhi. 2014 Apr;49(4):204-9.
To compare a developed absorbable chitosan/collagen membrane (CCM) with a standard biodegradable collagen membrane for the treatment of implant dehiscence-type defect in dog model.
The right four mandibular premolars and the first molar were extracted in each of 10 beagle dogs.Four months later, acute buccal dehiscence-type defects were surgically created following implant site preparation in each dog. Using self-control, defects were randomly assigned to four different groups: CCM-1 (with the ratio of chitosan and collagen of 40: 1), CCM-2(with the ratio of chitosan and collagen of 20: 1), Bio-Gide collagen membrane (BG collagen), control. The animals were sacrificed after 4 (3 animals), 8 (3 animals) and 12 (4 animals) weeks of healing interval for histological observation and histomorphometrical analysis including defect length (DL), new bone height (NBH), bone-to-implant contact (BIC) and area of new bone fill (BA).
Newly formed bone was observed in all the groups and became mature with time. At 8 weeks, increased mean NBH and BIC values were obtained for all the groups, the mean NBH values of the CCM-1, CCM-2 and BG groups [( 1.1 0 ± 0.11)∼(1.48 ± 0.07) mm]were significantly higher than that of the control [(0.74 ± 0.12) mm] (P < 0.05). At 12 weeks, the membranes treated groups obtained more mean NBH,BIC and BA values compared with the control. The CCM-1 groups showed the highest mean NBH value [(1.91 ± 0.25) mm], which was significantly higher than the control [(1.20 ± 0.34) mm](P < 0.05).However, no statistically significant differences in BIC and BA were found between membrane groups and control and among the membranes treated groups.
The results of this study demonstrated that the developed CCM can enhance bone regeneration and obtaine similar amounts of newly formed bone compared with defects regenerated with a standard collagen membrane.
在犬模型中,将一种研发的可吸收壳聚糖/胶原膜(CCM)与标准可生物降解胶原膜用于治疗种植体裂开型缺损进行比较。
对10只比格犬每只拔除右侧4颗下颌前磨牙和第一磨牙。4个月后,在每只犬的种植位点准备完成后,手术制造急性颊侧裂开型缺损。采用自身对照,缺损随机分为4组:CCM-1组(壳聚糖与胶原比例为40:1)、CCM-2组(壳聚糖与胶原比例为20:1)、Bio-Gide胶原膜组(BG胶原组)、对照组。在愈合4周(3只动物)、8周(3只动物)和12周(4只动物)后处死动物,进行组织学观察和组织形态计量学分析,包括缺损长度(DL)、新骨高度(NBH)、骨与种植体接触(BIC)以及新骨填充面积(BA)。
所有组均观察到新形成的骨组织,且随时间成熟。8周时,所有组的平均NBH和BIC值均增加,CCM-1组、CCM-2组和BG组的平均NBH值[(1.10±0.11)~(1.48±0.07)mm]显著高于对照组[(0.74±0.12)mm](P<0.05)。12周时,与对照组相比,膜处理组获得更高的平均NBH、BIC和BA值。CCM-1组的平均NBH值最高[(1.91±0.25)mm],显著高于对照组[(1.20±0.34)mm](P<0.05)。然而,膜处理组与对照组之间以及膜处理组之间的BIC和BA无统计学显著差异。
本研究结果表明,研发的CCM可促进骨再生,与标准胶原膜再生的缺损相比,能获得相似量的新形成骨。